IMPORTANT RESEARCH PROJECT
| Title of Proposal | Preclinical evaluation of the anticancer efficacy and safety of novel targeted nanoformulations in mouse models of colorectal and liver cancer (1/3) |
| Project Funding Agency | Revitalization Plan |
| 共同主持人 | Assistant Professor Li-Ling Wu |
| Project Execution Period | 1140101~1161231 |
| Title of Proposal | Breakthrough in HBV Treatment: Evaluation of Comprehensive Drug Trials in Mouse Animal Models |
| Project Director | Assistant Professor Li-Ling Wu |
| Project Funding Agency | Industry-university cooperation |
| Project Execution Period | 1140301~1141231 |
| Title of Proposal | National Human Microbiome Core Facility |
| Project Director | Professor Chun-Ying Wu |
| Project Funding Agency | National Science and Technology Council |
| Project Execution Period | 1140501~1150430 |
| Title of Proposal | Research on AKK bacteria and related metabolites as biomarkers or adjuvant therapies for hepatocellular carcinoma (2/4) |
| Project Director | Professor Chun-Ying Wu |
| Project Funding Agency | National Science and Technology Council |
| Project Execution Period | 1140501~1150430 |
| Title of Proposal | Research on AKK bacteria and related metabolites as biomarkers or adjuvant therapies for hepatocellular carcinoma (1/4) |
| Project Director | Professor Chun-Ying Wu |
| Project Funding Agency | National Science and Technology Council |
| Project Execution Period | 1130501~1140430 |
| Title of Proposal | This study explores the molecular mechanisms of gut microbiota-gut-liver axis intervention in metabolic-related fatty liver disease induced by a high-fat diet, focusing on leaky gut, gut microbiota-bile acid-FXR signaling, and immune metabolic reprogramming. |
| Project Director | Assistant Professor Li-Ling Wu |
| Project Funding Agency | National Science and Technology Council |
| Project Execution Period | 112/08/01~115/07/31 |
| Title of Proposal | The role of Nfil3 in obesity-related kidney disease |
| Project Director | Assistant Professor Li-Ling Wu |
| Project Funding Agency | Ministry of Health and Welfare Taoyuan Hospital |
| Project Execution Period | 1140101~1141231 |
| Title of Proposal | The Roles of Gut Microbiota in the Outcomes of Chronic Hepatitis and Hepatocellular Carcinoma: Clinical Studies, Big Data Studies, Animal Experiments, and Multi-Omics Studies( Iv ) |
| Project Funding Agency | National Science and Technology Council |
| Project Director | Professor Chun-Ying Wu |
| Project Execution Period | 1120501~1130430 |
| Title of Proposal | Establishment of Research Collaboration and Technical Service for National Human Microbiome Core Facilities |
| Project Funding Agency | National Science and Technology Council |
| Project Director | Professor Chun-Ying Wu |
| Project Execution Period | 1120501~1130430 |
| Title of Proposal | Expanding the comprehensive HBV drug trial evaluation program |
| Co-Project Director | Assistant Professor Li-Ling Wu |
| Project Funding Agency | Jutianyi |
| Project Execution Period | 1130401~1140331 |
| Title of Proposal | Isolation and characteristics of probiotics with potential applications for improving the gastrointestinal health of animals (I) |
| Co-Project Director | Associate Professor Cheng-Yen Kao |
| Project Funding Agency | |
| Project Execution Period | 1121201~1131130 |
| Title of Proposal | Cellular drug screening test evaluation |
| Co-Project Director | Assistant Professor Li-Ling Wu |
| Project Funding Agency | Jutianyi |
| Project Execution Period | 1120501~1130831 |
| Title of Proposal | Isolation and characterization of probiotics with potential applications for the prevention of vaginal infections (I) |
| Co-Project Director | Associate Professor Cheng-Yen Kao |
| Project Funding Agency | Cooperation Project Program |
| Project Execution Period | 1120301~1130229 |